Briefing
Remission Assessment by Circulating Tumor DNA in Large B-Cell Lymphoma
ctDNA used to assess remission in large B-cell lymphoma, evaluating residual disease after therapy. Level 2. Complements earlier Kurtz 2018 work.
- Design: paper
- Assay: ctDNA MRD for remission assessment in LBCL